Susan joined Dechra Pharmaceuticals in June 2005, retiring in 2021 as Chief Scientific Officer. A veterinarian with over 30 years’ experience in the industry, she led a team of approximately 150 staff around the globe responsible for product development, registering new products and maintaining the registrations of Dechra’s existing products. She assumed the Business Development role in 2015, searching out new products to continue to fill Dechra’s product development pipeline. Susan was appointed as Chief Scientific Officer in January 2020, bringing together Business Development, Product Development and Regulatory Affairs.
Prior to joining Dechra, Dr. Longhofer worked for Virbac Corporation, Heska Corporation and Merck Research Laboratories.
Dr. Longhofer holds an MS and a DVM in Veterinary Science and is a Diplomate, American College of Veterinary Internal Medicine. She spends her time in Florida and North Carolina, USA.
Dr. Longhofer joined NovaQuest’s Animal Health Strategic Advisory Committee in June 2022.